ATS View
한국어

Oscotec KRX:039200KOSDAQ

오스코텍 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days4
DART filings, 7 days0
Articles tracked4since Sep 11

In Q2 2026, Oscotec reported revenue of ₩52.6bn, up 425.6% year on year, and operating profit of ₩38.7bn. Oscotec (오스코텍) appeared in 4 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 4 articles. It was most often mentioned alongside Yuhan.

Oscotec quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩52.6bn+425.6%₩38.7bn₩40.8bn
Q1 2026₩3.6bn+88.4%−₩10.0bn−₩5.0bn
Q4 2025 derived check units₩78.9bn–₩61.4bn₩64.0bn
Q3 2025₩8.9bn-69.2%−₩373m₩648m
Q2 2025₩10.0bn+544.7%−₩632m−₩2.5bn
Q1 2025₩1.9bn+82.3%−₩8.3bn−₩7.8bn
Q4 2024 derived₩2.3bn+664.0%−₩7.0bn−₩6.9bn
Q3 2024₩29.1bn+1613.0%₩19.6bn₩19.3bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Oscotec top stories 2 weeks, by number of outlets

  1. 1
    오스코텍, 프리 갈리앵 코리아 '최우수 제약 제품상'
    3 outlets · 3 articlesFirst report Sep 11 10:47 파이낸셜포스트
  2. 2
    유한양행 렉라자, '프리 갈리앵 코리아' 첫 최우수 제약제품상 수상
    1 outlets · 1 articlesFirst report Sep 11 10:22 PRESS9Yuhan

Latest Oscotec news Korean headlines